Loading...
Raltegravir in treatment naïve patients
Raltegravir is the first integrase inhibitor approved for the treatment of HIV infection based on the superior efficacy it showed compared to optimized backbone therapy alone in patients harboring multidrug resistant viruses. Studies on naïve patients showed comparable efficacy of raltegravir and ef...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3516825/ https://ncbi.nlm.nih.gov/pubmed/19959413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-783X-14-S3-22 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|